Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A 23-year-old shared his 4-year hair treatment journey, using high-dose oral minoxidil and RU58841 initially, then switching to topical finasteride, and finally to dutasteride, which he found effective. He experienced lower libido as a side effect but is satisfied with the hair maintenance results.

User found hair loss stabilization without side effects using a topical solution of 0.008% Finasteride, 2% RU, and Stemoxydine. Other treatments like Eucapil, Fluridil, RU-monotherapy, and Pyrilutamide didn't work for them.

Verteporfin is being explored for its potential to improve hair transplant outcomes by reducing scarring and increasing donor hair follicles. There is skepticism about the results, with some claiming misleading presentation of evidence.

A 19-year-old is using topical minoxidil 7% and finasteride 0.1% foam, along with a laser cap, to combat hair loss. They report progress despite initial shedding and are considering switching to oral finasteride in the future for convenience.

The conversation discusses the HMI-115 trial for hair loss, which was expected to end around July 2023 due to a late participant. Participants also mention Minoxidil, finasteride, and RU58841 as treatments.

The user shared progress pictures after using a topical treatment of 0.3% finasteride and 6% minoxidil once a day for a year, noting improvement in the front but needing suggestions for the crown. They confirmed using a product from Hims.

The conversation discusses experiences with NMN supplementation for hair growth, with some users reporting increased hair growth activity and others seeing no significant changes. OP has been using dutasteride and oral minoxidil, and recently added NMN, noticing increased shedding, which they hope indicates new hair growth.

PP405, a potential hair loss treatment, is facing delays in releasing Phase 2 results, causing frustration among users who compare it to past failed treatments. Despite skepticism, some remain hopeful about PP405's future, while others discuss alternative treatments like Clascoterone and its expected market release.

The user experienced significant hair regrowth after three months using a topical combination of minoxidil and dutasteride. They reported no side effects and were surprised by the progress, despite initial skepticism.

Kintor announced Phase 3 results for pyrilutamide, a hair loss treatment, in China. The conversation is focused on this announcement and its implications for hair loss treatment.

The conversation discusses switching from RU58841 to pyrilutamide for hair loss treatment, with users generally recommending staying on RU58841 if it is effective. RU58841 is sourced from GeneTherica, which ships worldwide.

The user shared their 4-month progress using a topical solution of 5% minoxidil and 0.1% finasteride, reporting initial shedding that stopped after 2.5 months and noticeable regrowth, especially in the crown area. They use Glenmark Hair4U F from India and have experienced no side effects.

A 30-year-old male experienced significant hair regrowth after five months of using topical minoxidil (5% foam) and oral dutasteride (0.5 mg daily). The user reported no side effects and was grateful for the progress, despite the rapid gains slowing down.

The user is using a combination of finasteride, dutasteride, oral and topical minoxidil, PRP, and stem cell treatments for hair loss. They report slowed shedding and new vellus hairs on the hairline, questioning if they are a strong responder to the treatment.

Veradermics' new hair loss treatment, VDPHL01, is likely a modified release oral minoxidil, which has received $75 million in funding for clinical trials. Despite skepticism about investing in a known treatment, some believe it could offer improved efficacy and reduced side effects.

A user added 1% NMN to their 5% minoxidil mix for hair loss, which also includes melatonin, ginkgo, nettle root, and plans to add caffeine. They are asking if anyone has tried topical NMN for hair growth.

The user tried finasteride, dutasteride, and oral minoxidil for hair loss with no success and was diagnosed with androgenetic alopecia. They are considering increasing dosages and trying other treatments like RU58841, GHK-CU, and clascoterone, while seeking further medical opinions.

The user shared progress pictures after 8 months of using oral minoxidil, initially finasteride, and then switching to dutasteride 3 times a week. They experienced some shedding but noticed healthier hair and are considering increasing the dutasteride dosage.

The user is updating on their 3-month progress using minoxidil (0.5mg twice daily) and microneedling once a week. They plan to consult a doctor about adding finasteride to their regimen.

The user is experiencing hair loss despite using dutasteride and minoxidil and is considering adding RU58841 or other treatments like microneedling. Suggestions include stopping smoking, trying dutasteride mesotherapy, using tretinoin, maintaining a healthy lifestyle, and possibly using a red light cap.

People have reported hair thickening with Pyrilutamide, particularly using a 1% concentration. Some users are curious about the availability of different concentrations like 0.9%.

Minoxidil 5% was used twice daily, leading to hair regrowth and increased density. The user plans to switch to oral minoxidil and finasteride, but currently uses a topical solution with 0.1% finasteride.

The user switched from finasteride to dutasteride and experienced hair regrowth with no side effects, using 2.5mg oral minoxidil and 0.5mg dutasteride. The user noticed improved mood due to more hair and found the treatment effective, starting at age 21.

PP405 is a topical gel being tested for hair regrowth in adults with androgenetic alopecia. Volunteers aged 18-55 are needed for a 16-week trial in several US locations.

NMN shows promise in promoting hair growth by reducing oxidative stress and weakening androgens. It may be a beneficial addition to hair loss treatments like Minoxidil and Finasteride.

The user improved their hair loss from a Norwood scale 2.5/3 to 1.5/2 using treatments including 2.5 mg dutasteride, RU58841, 15 mg oral minoxidil, isoflavones, NAC, pumpkin seed oil, NAD+, and Vipelin, but still experiences temple recession. Other users expressed concern over the high dosages of oral minoxidil and dutasteride.

A 37-year-old man is using finasteride and topical minoxidil to combat hair loss, aiming to regain his previous Afro hairstyle. He previously tried a finasteride-minoxidil spray and dutasteride without lasting results, but reports increased libido and no side effects from these treatments.

A 23-year-old male experienced significant hair improvement over 9 months using dutasteride, minoxidil, finasteride, PRP, and red light therapy, with no side effects. He plans to continue treatment for 6 more months before deciding on a hair transplant.

Setipiprant and bimatoprost are being discussed as potential future treatments for hair loss. Some individuals have started testing setipiprant before FDA approval, but no progress updates are available yet.

A 21-year-old is using a combination of topical finasteride, topical and oral minoxidil, a liquid multivitamin, collagen powder, liquid biotin, microneedling, and red light therapy to address hair thinning. They are cautious about side effects and unsure if their hair loss is due to DHT or past brushing habits.